361 related articles for article (PubMed ID: 31993861)
1. Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancer.
Qian XL; Xu P; Zhang YQ; Song YM; Li YQ; Li WD; Jiang CY; Shen BB; Zhang XM; Zhang LN; Fu L; Guo XJ
Breast Cancer Res Treat; 2020 Apr; 180(2):311-319. PubMed ID: 31993861
[TBL] [Abstract][Full Text] [Related]
2. Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy.
Malone MK; Smrekar K; Park S; Blakely B; Walter A; Nasta N; Park J; Considine M; Danilova LV; Pandey NB; Fertig EJ; Popel AS; Jin K
Cancer Biol Ther; 2020 Jun; 21(6):560-569. PubMed ID: 32213106
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
4. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
5. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-34 contributes to poor prognosis in triple-negative breast cancer.
Kajihara N; Kitagawa F; Kobayashi T; Wada H; Otsuka R; Seino KI
Breast Cancer; 2020 Nov; 27(6):1198-1204. PubMed ID: 32578004
[TBL] [Abstract][Full Text] [Related]
7. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
8. Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration.
Khalid F; Takagi K; Sato A; Yamaguchi M; Guestini F; Miki Y; Miyashita M; Hirakawa H; Ohi Y; Rai Y; Sagara Y; Sasano H; Suzuki T
Breast Cancer; 2023 Sep; 30(5):748-757. PubMed ID: 37178415
[TBL] [Abstract][Full Text] [Related]
9. The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer.
Yan Z; Zhong Z; Shi C; Feng M; Feng X; Liu T
Cancer Biol Ther; 2024 Dec; 25(1):2355705. PubMed ID: 38778753
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and immunohistochemical characteristics of breast cancer patients from Northeast India with special reference to triple negative breast cancer: A prospective study.
Sultana R; Kataki AC; Barthakur BB; Sarma A; Bose S
Curr Probl Cancer; 2020 Oct; 44(5):100556. PubMed ID: 32044043
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
Tsai YF; Huang CC; Lin YS; Hsu CY; Huang CP; Liu CY; Chiu JH; Tseng LM
Cancer Immunol Immunother; 2021 Aug; 70(8):2339-2351. PubMed ID: 33512556
[TBL] [Abstract][Full Text] [Related]
12. Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells.
Jiang F; Li Y; Si L; Zhang Z; Li Z
Cell Biol Toxicol; 2019 Aug; 35(4):361-371. PubMed ID: 30612216
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma.
Sahin Ozkan H; Ugurlu MU; Yumuk PF; Kaya H
Pathol Oncol Res; 2020 Oct; 26(4):2733-2745. PubMed ID: 32681436
[TBL] [Abstract][Full Text] [Related]
14. A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6.
Tian W; Wang L; Yuan L; Duan W; Zhao W; Wang S; Zhang Q
Cancer Sci; 2016 Jul; 107(7):882-9. PubMed ID: 27145494
[TBL] [Abstract][Full Text] [Related]
15. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
Wang K; Shen T; Siegal GP; Wei S
Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
Dogra A; Doval DC; Sardana M; Chedi SK; Mehta A
Asian Pac J Cancer Prev; 2014; 15(24):10577-83. PubMed ID: 25605142
[TBL] [Abstract][Full Text] [Related]
17. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
18. Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?
Harada TL; Uematsu T; Nakashima K; Sugino T; Nishimura S; Takahashi K; Hayashi T; Tadokoro Y; Watanabe J; Nakamoto S; Ito T
Eur Radiol; 2020 Jun; 30(6):3363-3370. PubMed ID: 32062698
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of MTDH and VEGF in triple-negative breast cancer].
Tan L; Qin H; Piao Y; Liu Z; Han Y; Song F; Xie X
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):827-32. PubMed ID: 26887512
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer.
Abdelrahman AE; Rashed HE; Abdelgawad M; Abdelhamid MI
Ann Diagn Pathol; 2017 Jun; 28():43-53. PubMed ID: 28648939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
